165 related articles for article (PubMed ID: 18223219)
21. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
Holm NT; Abreo F; Johnson LW; Li BD; Chu QD
Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
[TBL] [Abstract][Full Text] [Related]
22. The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.
Papadopoulou E; Tripsianis G; Anagnostopoulos K; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(2):113-21. PubMed ID: 18237248
[TBL] [Abstract][Full Text] [Related]
23. Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy.
Saigusa S; Toiyama Y; Tanaka K; Yokoe T; Okugawa Y; Fujikawa H; Matsusita K; Kawamura M; Inoue Y; Miki C; Kusunoki M
Int J Oncol; 2011 Mar; 38(3):655-63. PubMed ID: 21240461
[TBL] [Abstract][Full Text] [Related]
24. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
[TBL] [Abstract][Full Text] [Related]
25. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients.
de Oliveira KB; Guembarovski RL; Oda JM; Mantovani MS; Carrera CM; Reiche EM; Voltarelli JC; da Silva do Amaral Herrera AC; Watanabe MA
Cytokine; 2011 Aug; 55(2):260-5. PubMed ID: 21592819
[TBL] [Abstract][Full Text] [Related]
26. Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis.
Manetti M; Liakouli V; Fatini C; Cipriani P; Bonino C; Vettori S; Guiducci S; Montecucco C; Abbate R; Valentini G; Matucci-Cerinic M; Giacomelli R; Ibba-Manneschi L
Ann Rheum Dis; 2009 Mar; 68(3):408-11. PubMed ID: 18930992
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
Pierga JY; Bidard FC; Mathiot C; Brain E; Delaloge S; Giachetti S; de Cremoux P; Salmon R; Vincent-Salomon A; Marty M
Clin Cancer Res; 2008 Nov; 14(21):7004-10. PubMed ID: 18980996
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of the stromal cell-derived factor 1 3'A mutation in pediatric human immunodeficiency virus type 1 infection.
Tresoldi E; Romiti ML; Boniotto M; Crovella S; Salvatori F; Palomba E; Pastore A; Cancrini C; de Martino M; Plebani A; Castelli G; Rossi P; Tovo PA; Amoroso A; Scarlatti G; ;
J Infect Dis; 2002 Mar; 185(5):696-700. PubMed ID: 11865429
[TBL] [Abstract][Full Text] [Related]
29. The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer.
Hassan S; Ferrario C; Saragovi U; Quenneville L; Gaboury L; Baccarelli A; Salvucci O; Basik M
Am J Pathol; 2009 Jul; 175(1):66-73. PubMed ID: 19497995
[TBL] [Abstract][Full Text] [Related]
30. Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer.
Bramwell VH; Doig GS; Tuck AB; Wilson SM; Tonkin KS; Tomiak A; Perera F; Vandenberg TA; Chambers AF
Breast Cancer Res Treat; 2009 Apr; 114(3):503-11. PubMed ID: 18437556
[TBL] [Abstract][Full Text] [Related]
31. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
[TBL] [Abstract][Full Text] [Related]
32. Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells.
Stellos K; Bigalke B; Langer H; Geisler T; Schad A; Kögel A; Pfaff F; Stakos D; Seizer P; Müller I; Htun P; Lindemann S; Gawaz M
Eur Heart J; 2009 Mar; 30(5):584-93. PubMed ID: 19109356
[TBL] [Abstract][Full Text] [Related]
33. [The role of SDF-1 and its receptor CXCR4 in tumor metastasis].
Chen H; Tan Y; Cai S; Ma W; Guo Z; Du J; Cai S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1180-3. PubMed ID: 18027722
[TBL] [Abstract][Full Text] [Related]
34. Stromal-derived factor-1alpha induces a non-canonical pathway to activate the endocrine-linked Tac1 gene in non-tumorigenic breast cells.
Corcoran KE; Malhotra A; Molina CA; Rameshwar P
J Mol Endocrinol; 2008 Mar; 40(3):113-23. PubMed ID: 18316470
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the stromal cell-derived factor 1-3'A gene polymorphism in pancreatic cancer.
Theodoropoulos GE; Panoussopoulos GS; Michalopoulos NV; Zambirinis CP; Taka S; Stamopoulos P; Gazouli M; Zografos G
Mol Med Rep; 2010; 3(4):693-8. PubMed ID: 21472301
[TBL] [Abstract][Full Text] [Related]
36. The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma.
Mazur G; Gębura K; Gieryng A; Butrym A; Wróbel T; Bogunia-Kubik K
Cytokine; 2013 Oct; 64(1):422-6. PubMed ID: 23711392
[TBL] [Abstract][Full Text] [Related]
37. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
38. Plasma testosterone and prognosis of postmenopausal breast cancer patients.
Micheli A; Meneghini E; Secreto G; Berrino F; Venturelli E; Cavalleri A; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Veronesi U; Formelli F
J Clin Oncol; 2007 Jul; 25(19):2685-90. PubMed ID: 17548841
[TBL] [Abstract][Full Text] [Related]
39. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis.
Ruiterkamp J; Ernst MF; van de Poll-Franse LV; Bosscha K; Tjan-Heijnen VC; Voogd AC
Eur J Surg Oncol; 2009 Nov; 35(11):1146-51. PubMed ID: 19398188
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery.
Kuru B; Camlibel M; Dinc S; Gulcelik MA; Gonullu D; Alagol H
Singapore Med J; 2008 Nov; 49(11):904-11. PubMed ID: 19037557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
